KIRSKE DAVID

PrivateCIK: 1276750
Location

BOSTON, MA

KIRSKE DAVID (EVP, Chief Financial Officer) reported 1 transaction at CTI BIOPHARMA CORP

Review the transaction codes below to understand the nature of each event.

InsiderKIRSKE DAVIDCIK 1276750
IssuerCTI BIOPHARMA CORPCIK 891293
Officer· EVP, Chief Financial Officer
Since Sep 2018
-1.68M
Net shares
Net seller
$159.7K
Total sold
0
Open market trades
0B · 0S
9
Total transactions
1.68M disposed
Non-Derivative Transactions1

Common Stock

Direct
U · U

Shares

17.55K

Price / share

$9.10

Trade value

$159.68K

% of position

New position
6/26/2023
17.55K0.00
Total

Net shares

17.55K

Net value

-$159.68K

Derivative Transactions8

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

25K shares

Shares

25K

Strike price

3.25

Held after

0.00

Exercisable

6/26/2023

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

315K shares

Shares

315K

Strike price

3.19

Held after

0.00

Exercisable

6/26/2023

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

83.40K shares

Shares

83.40K

Strike price

4.14

Held after

0.00

Exercisable

6/26/2023

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

270.22K shares

Shares

270.22K

Strike price

0.9489

Held after

0.00

Exercisable

6/26/2023

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

340K shares

Shares

340K

Strike price

1.00

Held after

0.00

Exercisable

6/26/2023

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

150K shares

Shares

150K

Strike price

3.30

Held after

0.00

Exercisable

6/26/2023

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

280K shares

Shares

280K

Strike price

4.49

Held after

0.00

Exercisable

6/26/2023

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

200K shares

Shares

200K

Strike price

4.55

Held after

0.00

Exercisable

6/26/2023
KIRSKE DAVID — Insider Transaction (Form 4) Filed Jun 26, 2023 | Finecho